Immunotherapy drug staves off lung cancer better than chemo in some newly treated patients
In a head-to-head comparison between the immunotherapy drug pembrolizumab and standard chemotherapy as a first-line therapy for advanced nonsmall cell lung cancer, patients taking pembrolizumab had… Read More »Immunotherapy drug staves off lung cancer better than chemo in some newly treated patients
